Single Administration of p2TA (AB103), a CD28 Antagonist Peptide, Prevents Inflammatory and Thrombotic Reactions and Protects against Gastrointestinal Injury in Total-Body Irradiated Mice

• Salida Mirzoeva,

  Affiliation Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Tatjana Paunesku,

  Affiliation Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• M. Beau Wanzer,

  Affiliation Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Anat Shirvan,

  Affiliation Atox Bio Ltd, Ness Ziona, Israel

  ⨯
• Raymond Kaempfer,

  Affiliation Department of Biochemistry and Molecular Biology, Institute of Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯
• Gayle E. Woloschak ,

  * E-mail: g-woloschak@northwestern.edu (GW); wmsmall@lumc.edu (WS)

  Affiliation Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• William Small Jr

  * E-mail: g-woloschak@northwestern.edu (GW); wmsmall@lumc.edu (WS)

  Affiliation Department of Radiation Oncology, Loyola University Stritch School of Medicine, Chicago, Illinois, United States of America

  ⨯